These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24897292)

  • 1. Pharmacogenetics of second-generation antipsychotics.
    Brennan MD
    Pharmacogenomics; 2014 Apr; 15(6):869-84. PubMed ID: 24897292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
    Correia CT; Almeida JP; Santos PE; Sequeira AF; Marques CE; Miguel TS; Abreu RL; Oliveira GG; Vicente AM
    Pharmacogenomics J; 2010 Oct; 10(5):418-30. PubMed ID: 19997080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of clinical response to risperidone.
    Llerena A; Berecz R; Peñas-Lledó E; Süveges A; Fariñas H
    Pharmacogenomics; 2013 Jan; 14(2):177-94. PubMed ID: 23327578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of antipsychoatics.
    Ozaki N
    Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polymorphisms of candidate pharmacokinetic and pharmacodynamic genes and their pharmacogenetic impacts on the effectiveness of risperidone maintenance therapy among Saudi children with autism.
    Shilbayeh SAR; Adeen IS; Alhazmi AS; Aljurayb H; Altokhais RS; Alhowaish N; Aldilaijan KE; Kamal M; Alnakhli AM
    Eur J Clin Pharmacol; 2024 Jun; 80(6):869-890. PubMed ID: 38421437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research.
    Blanc O; Brousse G; Meary A; Leboyer M; Llorca PM
    Fundam Clin Pharmacol; 2010 Apr; 24(2):139-60. PubMed ID: 19702693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacogenetics of treatment with olanzapine.
    Zubiaur P; Soria-Chacartegui P; Villapalos-García G; Gordillo-Perdomo JJ; Abad-Santos F
    Pharmacogenomics; 2021 Sep; 22(14):939-958. PubMed ID: 34528455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the common MC4R rs17782313 polymorphism with antipsychotic-related weight gain.
    Czerwensky F; Leucht S; Steimer W
    J Clin Psychopharmacol; 2013 Feb; 33(1):74-9. PubMed ID: 23277235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical pharmacogenetics in the treatment of schizophrenia].
    Saito M; Yasui-Furukori N; Kaneko S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial.
    Koller D; Saiz-Rodríguez M; Zubiaur P; Ochoa D; Almenara S; Román M; Romero-Palacián D; de Miguel-Cáceres A; Martín S; Navares-Gómez M; Mejía G; Wojnicz A; Abad-Santos F
    Br J Clin Pharmacol; 2020 Oct; 86(10):2051-2062. PubMed ID: 32250470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compilation of a comprehensive gene panel for systematic assessment of genes that govern an individual's drug responses.
    Feng J; Sun J; Wang MZ; Zhang Z; Kim ST; Zhu Y; Sun J; Xu J
    Pharmacogenomics; 2010 Oct; 11(10):1403-25. PubMed ID: 21047203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects.
    Koller D; Belmonte C; Lubomirov R; Saiz-Rodríguez M; Zubiaur P; Román M; Ochoa D; Carcas A; Wojnicz A; Abad-Santos F
    J Psychopharmacol; 2018 Nov; 32(11):1212-1222. PubMed ID: 30251598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic studies of response to risperidone and other newer atypical antipsychotics.
    Lane HY; Lee CC; Liu YC; Chang WH
    Pharmacogenomics; 2005 Mar; 6(2):139-49. PubMed ID: 15882132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of clozapine response and induced weight gain: A comprehensive review and meta-analysis.
    Gressier F; Porcelli S; Calati R; Serretti A
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):163-185. PubMed ID: 26792444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers.
    Zubiaur P; Soria-Chacartegui P; Koller D; Navares-Gómez M; Ochoa D; Almenara S; Saiz-Rodríguez M; Mejía-Abril G; Villapalos-García G; Román M; Martín-Vílchez S; Abad-Santos F
    Biomed Pharmacother; 2021 Jan; 133():111087. PubMed ID: 33378980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.